Quadramet and blood creatinine increased Patient Reports February 12, 2012
Quadramet Side Effects Report #4680208-0
Quadramet side effect was reported by a Physician from on Dec 01, 2004. Male patient was diagnosed with prostate cancer metastatic and was treated with Quadramet. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urine present, haemoglobin decreased, lymphadenopathy, obstructive uropathy. Quadramet dosage: unknown. During the same period patient was treated with ZOMETA, GOSERELIN, CAPTOPRIL W, IBUPROFEN, PARACETAMOL, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
Quadramet Side Effects Report #5150999-3
Quadramet side effect was reported by a Health Professional from UNITED KINGDOM on Oct 25, 2006. Male patient, 76 years of age, weighting 151.5 lb, was diagnosed with prostate cancer
and was treated with Quadramet. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, anxiety
, atrial fibrillation
, blood creatinine increased, blood urea increased, cardiac failure congestive, left ventricular failure, metastases to lung, mitral valve incompetence. Quadramet dosage: unknown. During the same period patient was treated with ADALAT, DIETHYLSTILBESTROL, OMEPRAZOLE, AMLODIPINE, TRAMADOL. Patient was hospitalized. Patient recovered.Quadramet Side Effects Report #5179514-5
Quadramet side effect was reported by a Health Professional from UNITED KINGDOM on Nov 13, 2006. Male patient, 76 years of age, weighting 151.5 lb, was diagnosed with prostate cancer
and was treated with Quadramet. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, anxiety
, atrial fibrillation
, blood alkaline phosphatase increased, blood creatinine increased, blood ph decreased, blood pressure increased, blood urea increased. Quadramet dosage: unknown. During the same period patient was treated with ADALAT, DIETHYLSTILBESTROL, OMEPRAZOLE, AMLODIPINE, TRAMADOL. Patient was hospitalized. Patient recovered.Quadramet Side Effects Report #4947020-6
Quadramet side effect was reported by a Physician from UNITED STATES on Apr 20, 2003. Male patient, weighting 177.5 lb, was diagnosed with metastatic pain and was treated with Quadramet. After drug was administered, patient experienced the following side effects: blood count abnormal, blood creatinine increased, blood urea increased, platelet count decreased, white blood cell count decreased. Quadramet dosage: unknown. Patient died on 04/01/2003.
Quadramet Side Effects Report #4652529-9
Quadramet side effect was reported by a Health Professional from on Apr 12, 2005. Female patient, 72 years of age, weighting 85.98 lb, was diagnosed with metastases to bone and was treated with Quadramet. After drug was administered, patient experienced the following side effects: anorexia, arthralgia, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, blood urea increased. Quadramet dosage: unknown. During the same period patient was treated with AROMASIN, SOLETON, CONIEL, MUCOSTA, AMOBAN, PURSENNID. Patient was hospitalized. Patient recovered.
Quadramet Side Effects Report #4952123-6
Quadramet side effect was reported by a Physician from SPAIN on Mar 02, 2006. Male patient, 45 years of age, weighting 163.1 lb, was treated with Quadramet. After drug was administered, patient experienced the following side effects: blood creatinine increased, haematuria, haemoglobin decreased, thrombocytopenia. Quadramet dosage: 74 ML 1 INTRAVENOUS. During the same period patient was treated with DIAZEPAM, DEXAMETHASONE, DIPYRONE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.
Quadramet Side Effects Report #4989817-2
Quadramet side effect was reported by a Physician from SPAIN on Mar 31, 2006. Male patient, 45 years of age, weighting 163.1 lb, was treated with Quadramet. After drug was administered, patient experienced the following side effects: blood creatinine increased, haematuria, haemoglobin decreased, metastases to bone, metastases to lung, pyelonephritis acute, renal ischaemia, thrombocytopenia, white blood cell count decreased. Quadramet dosage: 74 ML, 1 DOSE, INTRAVENOUS. During the same period patient was treated with DIAZEPAM, DEXAMETHASONE, DIPYRONE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.
Quadramet and blood creatinine increased 